In the mucosa of patients with IBD, there is an accumulation of pro-inflammatory macrophages that produce large amounts of IL-1β, IL-6, TNF-α, reactive oxygen intermediates, and nitric oxide, making them different from the macrophages in the healthy intestine (Singh et al., 2016). This evidence concerns the gene IL1B and inflammatory bowel disease.